Contemporary study of multiple sclerosis disability in South East Wales

被引:2
|
作者
Harding, Katharine Elizabeth [1 ,6 ]
Ingram, Gillian [2 ]
Tallantyre, Emma Clare [3 ,4 ]
Joseph, Fady [1 ]
Wardle, Mark [3 ]
Pickersgill, Trevor P. [3 ]
Willis, Mark D. [3 ]
Tomassini, Valentina [4 ,5 ]
Pearson, Owen Rhys [2 ]
Robertson, Neil P. [3 ,4 ]
机构
[1] Aneurin Bevan Univ Hlth Board, Dept Neurol, Newport, Wales
[2] Swansea Bay Univ Hlth Board, Neurol Dept, Swansea, Wales
[3] Cardiff & Vale Univ Hlth Board, Helen Durham Ctr Neuroinflammatory Dis, Cardiff, Wales
[4] Cardiff Univ, Inst Psychol Med & Neurol, Cardiff, Wales
[5] Univ Gabriele Annunzio Chieti Pescara, Inst Adv Biomed Technol ITAB, Dept Neurosci & Imaging & Clin Sci, Multiple Sclerosis Ctr,Neurol Clin,SS Annunziata H, Chieti, Italy
[6] Aneurin Bevan Univ Hlth Board, Dept Neurol, Newport NP18 3XQ, Wales
来源
关键词
epidemiology; multiple sclerosis; NATURAL-HISTORY; DIAGNOSTIC-CRITERIA; PROGRESSION; ONSET; PREVALENCE; GUIDELINES; REVISIONS; MORTALITY; REGISTRY; TRENDS;
D O I
10.1136/jnnp-2022-330013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundA contemporary understanding of disability evolution in multiple sclerosis (MS) is an essential tool for individual disease management and planning of interventional studies. We have used prospectively collected longitudinal data to analyse disability progression and variation in a British MS cohort. MethodsCox proportional hazards regression was used to estimate hazard of Expanded Disability Status Scale (EDSS) 4.0 and 6.0. A continuous Markov model was used to estimate transitional probabilities for individual EDSS scores. Models were adjusted for age at MS onset, sex and disease-modifying treatments (DMTs) exposure. Results2135 patients were included (1487 (70%) female, 1922 (89%) relapsing onset). 865 (41%) had used DMTs. Median time to EDSS 4.0 and 6.0 was 18.2 years (95% CI 16.3 to 20.2) and 22.1 years (95% CI 20.5 to 24.5). In the Markov model, the median time spent at EDSS scores of <6 (0.40-0.98 year) was shorter than the time spent at EDSS scores of >= 6 (0.87-4.11 year). Hazard of change in EDSS was greatest at EDSS scores <6 (HR for increasing EDSS: 1.02-1.33; decreasing EDSS: 0.34-1.27) compared with EDSS scores >= 6 (HR for increasing EDSS: 0.08-0.61; decreasing EDSS: 0.18-0.54). ConclusionsThese data provide a detailed contemporary model of disability outcomes in a representative population-based MS cohort. They support a trend of increasing time to disability milestones compared with historical reference populations, and document disability variation with the use of transitional matrices. In addition, they provide essential information for patient counselling, clinical trial design, service planning and offer a comparative baseline for assessment of therapeutic interventions.
引用
收藏
页码:272 / 279
页数:8
相关论文
共 50 条
  • [31] Measurement of disability in multiple sclerosis
    Gray, Orla
    Butzkueven, Helmut
    NEUROLOGY ASIA, 2008, 13 : 153 - 156
  • [32] ON EVALUATION OF DISABILITY IN MULTIPLE SCLEROSIS
    KURTZKE, JF
    NEUROLOGY, 1961, 11 (08) : 686 - +
  • [33] Use of cannabis based products in patients with progressive multiple sclerosis in South West Wales
    Watson, L.
    Pearson, O. R.
    Ingram, G.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 804 - 805
  • [34] CLEAR RED WATER? THE EFFECT OF CAPPED FUNDING FOR HIGH COST MULTIPLE SCLEROSIS DISEASE MODIFYING TREATMENT ON SUBSEQUENT UPTAKE IN SOUTH EAST WALES
    Pickersgill, T. P.
    Robertson, N. P.
    Coates, L.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (01): : 111 - 111
  • [35] Impact of Concomitant Diabetes on Disability in Multiple Sclerosis: A Retrospective Study
    Ali, Nabil
    Izzo, Anthony
    Riskind, Peter
    Kane, Kevin
    Garg, Neeta
    NEUROLOGY, 2011, 76 (09) : A472 - A473
  • [36] The multiple sclerosis PRISMS study:: Prevention of relapses and disability by interferon β-1a subcutaneously in multiple sclerosis
    Ebers, GC
    Oger, J
    Paty, D
    Li, D
    Freedman, M
    Hartung, HP
    Hommes, O
    McLeod, J
    Sandberg, M
    Wikström, J
    Carton, H
    Hughes, RAC
    Pancelius, M
    Medaer, R
    Blumhardt, L
    Barnes, D
    Bertelsmann, F
    Chofflon, M
    Kappos, L
    King, J
    Newsom-Davis, J
    Sindic, C
    Uitehaag, B
    Van Doom, P
    Bates, D
    Dupont, F
    Galazka, A
    Hyde, R
    Pernin, MO
    Abdul-Ahad, A
    ANNALS OF NEUROLOGY, 1997, 42 (06) : 986 - 986
  • [37] Disability in multiple sclerosis is associated with vascular factors: An ultrasound study
    Kemp, Merlisa C.
    Johannes, Clint
    van Rensburg, Susan J.
    Kidd, Martin
    Isaacs, Ferial
    Kotze, Maritha J.
    Engel-Hills, Penelope
    JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2023, 54 (02) : 247 - 256
  • [38] Impact of Concomitant Diabetes on Disability in Multiple Sclerosis: A Retrospective Study
    Zhang, Jiaying
    Ali, Nabil
    Glidden, Barbara
    Izzo, Anthony
    Riskind, Peter
    Kane, Kevin
    Garg, Neeta
    NEUROLOGY, 2012, 78
  • [39] Socioeconomic status and disability progression in multiple sclerosis A multinational study
    Harding, Katharine E.
    Wardle, Mark
    Carruthers, Robert
    Robertson, Neil
    Zhu, Feng
    Kingwell, Elaine
    Tremlett, Helen
    NEUROLOGY, 2019, 92 (13) : E1497 - E1506
  • [40] A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
    Brex, PA
    Ciccarelli, O
    O'Riordan, JI
    Sailer, M
    Thompson, AJ
    Miller, DH
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03): : 158 - 164